GCA
CMD

Gideon Capital Advisors’s Cantel Medical Corporation CMD Stock Holding History

Gideon Capital Advisors’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,800
Closed -$442K – 543
2018
Q3 		$442K Buy
+4,800
New +$457K 0.21% 167

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Gideon Capital Advisors's CMD Position: Q4 2018 in Review

Gideon Capital Advisors sold out of Cantel Medical Corporation (CMD) in Q4 2018, closing a stake of 4,800 shares — an estimated $442K sold.

Gideon Capital Advisors first reported a position in CMD in Q3 2018 and held it in 1 quarter. The position peaked at $442K in Q3 2018. 253 funds tracked by Wall St. Rank hold CMD as of Q4 2018.

  • Gideon Capital Advisors reported no remaining Cantel Medical Corporation position as of Q4 2018 after selling out during the quarter.
  • Gideon Capital Advisors sold 4,800 Cantel Medical Corporation shares in Q4 2018, an estimated $442K.
  • Gideon Capital Advisors first reported a position in Cantel Medical Corporation in Q3 2018 and held it in 1 quarter.
  • Gideon Capital Advisors's Cantel Medical Corporation position peaked at $442K in Q3 2018.
  • 253 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2018.

Based on Gideon Capital Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.